克洛桑特的抗菌活性对抗抗甲素耐药的金黄色葡萄球菌及其生物膜
1Department of Thoracic Surgery, Affiliated Changsha Hospital of Xiangya School of Medicine (First Hospital of Changsha), Central South University, Changsha 410005, China. ttt202305m@126.com.
概括
抗寄生虫药物克洛桑特尔显示出强大的抗菌活性对金黄色葡萄球菌 (S. aureus) 和其生物膜. 这项研究表明,克洛桑是治疗低细胞毒性黄金色杆菌感染的有希望的候选人.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 药物重用 药物重用
背景情况:
- 黄金葡萄球菌 (S. aureus) 的抗菌素耐药性构成了重大的临床挑战.
- 迫切需要有效的治疗方法来对抗多药物耐药的金黄色细菌及其生物膜.
研究的目的:
- 调查抗寄生虫药物克洛桑特尔对抗甲素耐药金黄色细菌 (MRSA) 和其生物膜的抗菌潜力.
- 探索克洛桑特尔作为一种新的治疗策略的药物重用.
主要方法:
- 微乳头稀释和磁盘扩散试验确定了S. aureus对克洛桑的敏感性.
- 时间杀伤曲线和扫描电子显微镜阐明了杀菌机制.
- 生物膜抑制和根除试验评估了抗生物膜活性.
- 细胞毒性通过使用肝细胞系的CCK-8测定来评估.
主要成果:
- 克洛桑特尔对甲基西林敏感和耐药的金黄色细菌菌株表现出强烈的活性,MIC从0.125到1.000μg/mL不等.
- 克洛桑特尔破坏了细菌细胞膜,并以剂量依赖的方式抑制了生物膜的形成.
- 即使在长时间暴露于亚抑制度后,也没有观察到对克洛桑的耐药性.
- 克洛桑特尔对人类肝细胞 (HepG2和LO2) 的细胞毒性非常低.
结论:
- 克洛桑特尔具有显著的抗菌和抗生物膜疗效,可以对黄金色白菌产生作用.
- 它的低细胞毒性和缺乏诱导性耐药性使其成为新型治疗策略的有希望的候选人.
- 克洛桑特尔的药物再利用提供了一种可行的方法来对抗金黄色细菌感染.
更多相关视频
09:39A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
17.7K
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
2.8K
相关概念视频
01:29Biofilms
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...